Close Menu
Home » Group B Strep Test From DiaSorin Molecular Cleared by FDA

Group B Strep Test From DiaSorin Molecular Cleared by FDA

Nov 26, 2018
|
staff reporter

NEW YORK (GenomeWeb) – DiaSorin Molecular announced today the US Food and Drug Administration has cleared the firm's Simplexa GBS Direct assay.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Keep Them or Not?

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

Dunno Whose It Is

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

Knowing Risk From a Young Age

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

Science Translational Medicine Paper Finds Drug Combo Boosts KRAS Inhibitor Efficacy in Lung Cancer

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.

What's Popular?

In Regulatory News & FDA Approvals

  1. Roche Gains FDA Clearance for Cobas Babesia Blood Test

  2. ACLA Urges FDA to Reconsider Recent PGx Enforcement Moves

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.